iloprost


SMILES CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
InChIKey HIFJCPQKFCZDDL-SGSAMSKHSA-N

Chemical properties

Hydrogen bond acceptors 3
Hydrogen bond donors 3
Rotatable bonds 8
Molecular weight (Da) 360.2

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Database connections

Bioactivities

Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
DP1 PD2R Human Prostanoid A pKi 6.0 6.3 6.6 Guide to Pharmacology
EP1 PE2R1 Human Prostanoid A pKi 5.6 6.8 8.0 Guide to Pharmacology
EP2 PE2R2 Human Prostanoid A pKi 5.7 5.7 5.7 Guide to Pharmacology
EP4 PE2R4 Human Prostanoid A pKi 4.64 5.66 6.68 Guide to Pharmacology
FP PF2R Human Prostanoid A pKi 6.2 6.2 6.2 Guide to Pharmacology
IP PI2R Human Prostanoid A pKi 7.5 7.75 8.0 Guide to Pharmacology
EP1 PE2R1 Mouse Prostanoid A pKi 7.7 7.7 7.7 Guide to Pharmacology
EP3 PE2R3 Rat Prostanoid A pKi 7.33 7.33 7.33 Guide to Pharmacology
EP3 PE2R3 Mouse Prostanoid A pKi 7.66 7.66 7.66 Guide to Pharmacology
EP1 PE2R1 Rat Prostanoid A pKi 7.9 7.9 7.9 Guide to Pharmacology
EP2 PE2R2 Rat Prostanoid A pKi 5.9 5.9 5.9 Guide to Pharmacology
EP4 PE2R4 Mouse Prostanoid A pKi 5.6 5.6 5.6 Guide to Pharmacology
EP2 PE2R2 Mouse Prostanoid A pKi 5.8 5.8 5.8 Guide to Pharmacology
IP PI2R Mouse Prostanoid A pKi 8.0 8.0 8.0 Guide to Pharmacology
EP3 PE2R3 Human Prostanoid A pKi 6.965 6.96 6.96 Guide to Pharmacology
TP TA2R Human Prostanoid A pKi 5.2 5.2 5.2 Guide to Pharmacology
Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
EP4 PE2R4 Human Prostanoid A pEC50 6.4 6.4 6.4 Guide to Pharmacology
EP3 PE2R3 Rat Prostanoid A pEC50 9.2 9.2 9.2 Guide to Pharmacology